文献速递心血管介入OCT

支架置入后OCT表现:严重贴壁不良与心脏事件

Clinical Implications of Poststent Optical Coherence Tomographic Findings: Severe Malapposition and Cardiac Events.
PubMed 文献 · JACC Cardiovasc Imaging · 2021-05-19

本研究基于Yonsei OCT注册研究(NCT02099162),连续纳入1290例患者1348个病变,评估支架置入后OCT表现对长期临床结局的影响。中位随访43.0个月,发现总贴壁不良体积≥7.0 mm³是主要安全事件(心源性死亡、靶血管相关心肌梗死或支架血栓)的独立预测因子(HR 6.12),而最小支架面积较小是器械导向临床终点(DoCE)的独立预测因子(HR 1.20)。

要点

  • 支架置入后OCT发现总贴壁不良体积≥7.0 mm³提示主要安全事件风险显著增加。
  • 最小支架面积(MSA)较小是器械导向临床终点(DoCE)的独立预测因子。
  • 支架边缘夹层、组织脱垂、血栓等OCT表现与DoCE发生无显著关联。

核心结论

  • 支架置入后严重贴壁不良(总贴壁不良体积≥7.0 mm³)与主要安全事件(心源性死亡、靶血管相关心肌梗死或支架血栓)风险增加独立相关。
  • 较小的最小支架面积(MSA)是器械导向临床终点(DoCE,包括心源性死亡、靶血管相关心肌梗死、支架血栓和靶病变血运重建)的独立预测因子。
  • 大多数其他支架置入后OCT异常表现(支架边缘夹层、组织脱垂、血栓、贴壁不良)与DoCE发生无显著关联。

研究设计与样本

  • 研究为Yonsei OCT注册研究(NCT02099162)的队列分析,连续纳入1290例患者共1348个病变。
  • 所有患者均接受药物洗脱支架置入,并在支架置入后立即行OCT检查。
  • 中位随访43.0个月(四分位距21.4–56.0个月),评估支架置入后OCT表现与临床结局的关系。

关键影像表现/征象

  • 支架置入后OCT评估包括支架边缘夹层、组织脱垂、血栓和贴壁不良等表现。
  • 严重贴壁不良定义为总贴壁不良体积(TMV)≥7.0 mm³。
  • 随访OCT(术后3、6或9个月)显示,支架置入后TMV≥7.0 mm³与晚期贴壁不良和未覆盖支架小梁的发生率更高相关。

诊断标准与关键数值

  • 严重贴壁不良的OCT标准为总贴壁不良体积(TMV)≥7.0 mm³。
  • TMV≥7.0 mm³预测主要安全事件(MSE)的HR为6.12(95%CI 1.88–19.95),p=0.003。
  • 最小支架面积(MSA)较小预测DoCE的HR为1.20(95%CI 1.00–1.43),p=0.045。

临床应用与阅片要点

  • 支架置入后OCT检查应关注总贴壁不良体积,TMV≥7.0 mm³提示需加强随访或干预。
  • OCT评估时应测量最小支架面积,MSA较小与靶病变血运重建风险增加相关。
  • 支架边缘夹层、组织脱垂和血栓等表现虽常见,但未显示与DoCE独立相关,报告时可结合其他因素综合判断。

局限性

  • 研究为单中心注册研究,结果外推需谨慎。
  • 随访OCT仅在部分患者中进行,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study sought to evaluate the impact of poststent optical coherence tomography (OCT) findings, including severe malapposition, on long-term clinical outcomes.

BACKGROUND: Suboptimal OCT findings following percutaneous coronary intervention (PCI) are highly prevalent; however, their clinical implications remain controversial.

METHODS: Of the patients registered in the Yonsei OCT registry, a total of 1,290 patients with 1,348 lesions, who underwent OCT immediately poststenting, were consecutively enrolled for this study. All patients underwent implantation of drug-eluting stents. Poststent OCT findings were assessed to identify predictors of device-oriented clinical endpoints (DoCE), including cardiac death, target vessel-related myocardial infarction (MI) or stent thrombosis, and target lesion revascularization (TLR). Significant malapposition criteria associated with major safety events (MSE) were also investigated, such as cardiac death, target vessel-related MI, or stent thrombosis.

RESULTS: The median follow-up period was 43.0 months (interquartile range [IQR] 21.4 to 56.0 months). The incidence rates of stent edge dissection, tissue prolapse, thrombus, and malapposition after intervention were not associated with occurrence of DoCE. However, patients with significant malapposition (total malapposition volume [TMV] ≥7.0 mm3] exhibited more frequent MSE. A smaller minimal stent area (MSA) was identified as an independent predictor for DoCE (hazard ratio [HR]: 1.20 [95% confidence interval [CI]: 1.00 to 1.43]; p = 0.045). Malapposition with TMV ≥7.0 mm3 was found to be an independent predictor of MSE (HR: 6.12 [95% CI: 1.88 to 19.95]; p = 0.003). Follow-up OCT at 3, 6, or 9 months after PCI showed that poststent TMV ≥7.0 mm3 was related to a greater occurrence of late malapposition and uncovered struts.

CONCLUSIONS: Although most suboptimal OCT findings were not associated with clinical outcomes, a smaller MSA was associated with DoCE, driven mainly by TLR, and significant malapposition with TMV ≥7.0 mm3 was associated with more MSE after PCI. (Yonsei OCT [Optical Coherence Tomography] Registry for Evaluation of Efficacy and Safety of Coronary Stenting; Yonsei OCT registry; NCT02099162).

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Kim BG, Kachel M, Kim JS, et al. Clinical Implications of Poststent Optical Coherence Tomographic Findings: Severe Malapposition and Cardiac Events. JACC Cardiovasc Imaging. 2021. PMID: 34023255. doi:10.1016/j.jcmg.2021.03.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。